Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
8 Patents
#112 in Cambridge
#2,098 in United Kingdom
Cantab Pharmaceuticals Research Limited
Forward Citations = 222
15 inventors:
Cantab Pharmaceuticals Research Limited
Forward Citations = 222
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
Stephen Charles Inglis (4 out of 8 patents)
Michael Edward Boursnell (3 out of 3 patents)
Stephen Edward Connor (2 out of 3 patents)
4. Anthony Charles Minson (2 out of 5 patents)
5. Jeremy Paddon Carmichael (2 out of 2 patents)
6. Nigel Richard Whittle (2 out of 2 patents)
7. Henry Stephen Thompson (2 out of 2 patents)
8. Mark Jonathan Wilson (2 out of 2 patents)
9. Michael E G Boursnell (1 out of 1 patent)
10. Roderic Simon O'Keeffe (1 out of 1 patent)
11. Michael Denis Johnston (1 out of 1 patent)
12. Nigel Kenneth Harry Slater (1 out of 1 patent)
13. Claire Alison Varley (1 out of 1 patent)
14. Peter Thomas Loudon (1 out of 1 patent)
15. Alan J Munro (1 out of 1 patent)
8 patents:
Company Overview
Cantab Pharmaceuticals Research Limited is a leading biopharmaceutical company specializing in the research and development of innovative therapeutics for neurological disorders. With a focus on developing novel treatments for diseases such as Alzheimer's and Parkinson's, Cantab Pharmaceuticals is committed to improving the lives of patients worldwide through cutting-edge science and research.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cantab Pharmaceuticals Research Limited. Retrieved from https://idiyas.com/company/cantab-pharmaceuticals-research
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]